培菲康与思密达交替应用预防小儿腹泻效果评价

《培菲康与思密达交替应用预防小儿腹泻效果评价》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、培菲康与思密达交替应用预防小儿腹泻病发生的研宄及效果评价黄联继戴朝福郭树淸（韶关学院医学院内、儿科教研室广东韶关512026中国）摘要.•目的探讨培菲康与思密达交替口服防止小儿腹泻病发生方法。方法120例2个月一2岁小儿随机分为微生态制剂培菲康与肠粘膜保护剂思密达交替口服作为预防组（58例）与不使用任何药物作为对照组（62例），通过12个月的临床观察，评价两组小儿腹泻病的发病情况。结果预防组小儿腹泻病的发病例数（发病率8.7%）明显低于对照组（发病率55.9%），经SPSS12.0统计软件的卡方检验两组具有显著差异，预防组优于对照组，预防组的观察中末出现不良现象。结论初探用培菲康与思密

2、达两药交替口服预防小儿腹泻病的发生，其方法便于小儿看护人的操作，易于掌握接受，不需较岛文化素养的人：医护人员易于向家庭推广；不增加家庭的经济负担，同时也提高社会效益。但在病例观察的对象数量及其它检验观察指标内容不够完善，有待进一步探索与证实。关键词：培菲康思密达预防小儿腹泻StudyandEffectiveEvaIuationonAIternateAppIicationofTakingBifidTripleViableandSmectaforPreventingChildrenDiarrheaDiseasesHuangLianjiDaiCaoFuGuoShuQing（MedicalCo

3、llegeofShaoguanUniversity,GuongdongShaoguan512026China）Abstract:objective:GofurtherintothemethodsforpreventingchildrendiarrheadiseasesbytakingBifidTripleViable(powder)andsmectaalternately.Methods:Twogroupsamong2-monthto2-year-oldbabies(120cases)aredividedintopreventingoneandcomparativeone.Thefor

4、merconsistsoffifty-eightcases,byalternatelytakingmicrobialpreparationBifidTripleViableandprotectionforbowelmucosasmectaandthelatteriscomposedofsixty-twocaseswithouttakinganymedicine.We’veevaluatedthedevelopingcasesofthetwogroupsbyone-yearclinicalobservation.Results:Theratesforcasesofthepreventin

5、ggroup(itsrateis8.7percent)areobviouslylowerthanthoseofthecomparativeone(itsrateis55.9percent).TherehasbeengreatdifferencebetweenthetwogroupsthroughthetestingofSPSS12.0.Thepreventinggroup,withunhealthytendenciesduringtheobservation,isbetterthanthecomparativeone.Conclusion:We’vefoundpracticalmeth

6、odsforpreventingchildrendiarrheadiseasesbytakingBifidTripleViableSmecta,whichcanbeoperatedbythepersonswholookafterthebabies.Itiseasyforfamiliesandmedicalworkerstointroducethemethods.Inthisway,itcanimprovesocialbenefitsaswellasnoeconomicburdenforfamilies.Howeverweshouldgofurtheranddemonstrateitin

7、improvingthenumbersofsubjectsandthetargetsofothertestingobservations.Keywords:BifidTripleViableSmectaPreventionChildrenDiarrheadiseases腹泻病是一种造成小儿营养不良，生长发育障碍，严重者引起水、电解质、酸碱紊乱而致死亡的疾病。有关资料报导m[21，80年代我国5岁以下儿童约1.2,每年约有3亿人次患腹泻痫，现在儿